Skip to content
value.today
Ventrus Biosciences Inc. logo

Ventrus Biosciences Inc.

🇺🇸 New York, New York, USABiotechnologyFounded 2005

Formerly South Island Biosciences, Inc.

Total raised
$3 M
1 round on record
Latest round
$3 M
Feb 2010
First round on record
Feb 2010
Today
Went public
See the company page

Ventrus Biosciences Inc. is listed today as Assembly Biosciences, Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Ventrus Biosciences Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2010$3 MNo. 1$2 to $10 million

Ventrus Biosciences Inc.: Raise no. 1, Feb 2010

Investors in this round

44 investors had bought by the notice of Apr 26, 2010: 44 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $5 M offered; $2 M still to sell
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$272,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Thom Rowland · Executive Officer, Director · Acting President
  • Joseph Felder · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • National Securities Corporation (CRD 7569) · Chicago, IllinoisSold in AZ, CA, CO, CT, FL, GA, IL, MO, NC, NE, NH, NJ, NY, OR, PA, SC, TX, WA, WI

Remarks in the notice

  • On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from teh proceeds of this offering.”

Signed by Thom Rowland, Acting President. Source: SEC Form D and 1 amendment, newest notice filed Apr 26, 2010. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Ventrus Biosciences Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2010).

    SEC Form D · Apr 2010

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2010

That is all the official record says: Ventrus Biosciences Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Ventrus Biosciences Inc. are on record.

Investors#

No investor of Ventrus Biosciences Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 44 investors.

Largest shareholders today

Institutions holding Assembly Biosciences, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Ventrus Biosciences Inc.
NameRoleNamed in
Thom RowlandActing PresidentApr 2010
Joseph FelderDirectorApr 2010
Thom RowlandActing PresidentApr 2010

Went public since 2010. Its SEC number is that of a company listed on a stock exchange.